Minerva Neurosciences | NERV - Ebit

Cena Akcji
5.51
Dzienna Zmiana
-0.51 -8.47%
Miesięcznie
-24.52%
Rocznie
280.00%
Q2 Prognozy TE
5.36




Ebit Zmiana Data
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Adma Biologics USD 62.75M 13.56M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD 56.04M 63.94M 2025-12
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12